Beta Release of v3.0 of OpenClinica Clinical Trials Software

Share Article

A beta version of the widely anticipated OpenClinica version 3.0 is currently available, including numerous new features and performance enhancements.

News Image
This release of OpenClinica builds on the software's strengths and includes a series of new features requested by our users

Akaza Research announces the beta release of OpenClinica 3.0. OpenClinica 3.0 brings a host of new capabilities to the rapidly growing open source electronic data capture (EDC) and clinical data management (CDM) software.

"This release of OpenClinica builds on the software's strengths and includes a series of new features requested by our users," said Paul Galvin, Development Manager at Akaza Research, the firm that distributes and supports OpenClinica. Some of the system improvements include source data verification tools, task-oriented navigation, study dashboards, and a web services API.

"In addition to adding features we have significantly improved the application's performance," added Galvin. "For example, users will notice an order of magnitude improvement in application speed for studies with over 10,000 subjects and over 1 million data points."

As open source software, OpenClinica is free for organizations to use and modify. The software may be downloaded from http://svn.akazaresearch.com/OpenClinica-3.0-distros/. The files contain scripts to install OpenClinica using the Postgres and Oracle databases. There is also an upgrade available for users utilizing the Postgres database from 2.5.x to 3.0 for people that want to test with their existing data.

In addition, a public demonstration instance is available at http://demo2.openclinica.org/OpenClinica-3.0.

OpenClinica's worldwide community of users and developers have contributed substantially to this release. According to Galvin, OpenClinica 3.0 "vividly demonstrates how a dynamic open source community can produce enterprise-quality software, and we are grateful to our collaborators who contributed to this release. Their efforts will benefit all organizations and people using OpenClinica."

About OpenClinica®:

OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical trial data management. OpenClinica facilitates data collection via electronic case report forms (eCRFs), and provides tools for data management and productive monitoring of clinical trials. OpenClinica supports leading CDISC standards and is designed to be compliant with industry and government regulations and guidelines such as 21 CFR Part 11, GCP, and HIPAA. OpenClinica is professionally supported by Akaza Research and has a worldwide open source community of over 6,000 users and developers. All versions of OpenClinica are freely available for download and use from http://www.openclinica.org.

About Akaza Research®:

Akaza Research provides professional open source software for clinical trials. The company's flagship product, OpenClinica, provides electronic data capture (EDC) and clinical data management (CDM) capabilities for clinical research. By bringing open source software into the mainstream of clinical research, Akaza is able to provide a cost effective technology solution that is more flexible and transparent than proprietary, closed systems. Akaza Research provides a full spectrum of OpenClinica-related products and services to a worldwide customer base through its OpenClinica EnterpriseTM solution. For more information about Akaza Research, see http://www.akazaresearch.com.

As open source software, OpenClinica is free for organizations to use and modify. The software may be downloaded from http://svn.akazaresearch.com/OpenClinica-3.0-distros/. The files contain scripts to install OpenClinica using the Postgres and Oracle databases. There is also an upgrade available for users utilizing the Postgres database from 2.5.x to 3.0 for people that want to test with their existing data.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ben Baumann
Akaza Research, LLC
617-621-8585 ext. 22
Email >
Visit website